These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 29702931)

  • 1. Comparative Analysis of Calendar Time-Specific and Conventional Propensity Score Analysis for Thiazolidinedione Use in Diabetes.
    Dilokthornsakul P; Chaiyakunapruk N; Jeanpeerapong N; Lee TA
    Value Health Reg Issues; 2014 May; 3():222-228. PubMed ID: 29702931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calendar time-specific propensity score analysis for observational data: a case study estimating the effectiveness of inhaled long-acting beta-agonist on asthma exacerbations.
    Dilokthornsakul P; Chaiyakunapruk N; Schumock GT; Lee TA
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):152-64. PubMed ID: 24150874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy.
    Mack CD; Glynn RJ; Brookhart MA; Carpenter WR; Meyer AM; Sandler RS; Stürmer T
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):810-8. PubMed ID: 23296544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events.
    Helin-Salmivaara A; Lavikainen P; Aarnio E; Huupponen R; Korhonen MJ
    PLoS One; 2014; 9(3):e90325. PubMed ID: 24614626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
    Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
    Mamza J; Mehta R; Donnelly R; Idris I
    Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.
    Dusetzina SB; Mack CD; Stürmer T
    PLoS One; 2013; 8(5):e63973. PubMed ID: 23667693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thiazolidinediones on cardiovascular events in patients with type 2 diabetes mellitus after drug-eluting stent implantation: a retrospective cohort study using the national health insurance database in Taiwan.
    Yeh HT; Hsieh CF; Tsai YW; Huang WF
    Clin Ther; 2012 Apr; 34(4):885-93. PubMed ID: 22440193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.
    Johannes CB; Koro CE; Quinn SG; Cutone JA; Seeger JD
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):504-12. PubMed ID: 17245800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality.
    Roussel R; Hadjadj S; Pasquet B; Wilson PW; Smith SC; Goto S; Tubach F; Marre M; Porath A; Krempf M; Bhatt DL; Steg PG
    Int J Cardiol; 2013 Aug; 167(4):1380-4. PubMed ID: 22560911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure.
    Aguilar D; Bozkurt B; Pritchett A; Petersen NJ; Deswal A
    J Am Coll Cardiol; 2007 Jul; 50(1):32-6. PubMed ID: 17601542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database.
    Rascati KL; Richards KM; Lopez D; Cheng LI; Wilson JP
    Clin Ther; 2011 Dec; 33(12):2016-20. PubMed ID: 22101160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.
    Ekström N; Svensson AM; Miftaraj M; Franzén S; Zethelius B; Eliasson B; Gudbjörnsdottir S
    Diabetes Obes Metab; 2016 Oct; 18(10):990-8. PubMed ID: 27282621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R; Rosenson RS; Fernandes AW; Khan M; Murray FT
    Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.
    Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH
    J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes.
    Yen FS; Wei JC; Hung YT; Hsu CY; Hwu CM; Hsu CC
    Front Microbiol; 2023; 14():1118000. PubMed ID: 36876083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones and Risk of Long-Term Dialysis in Diabetic Patients with Advanced Chronic Kidney Disease: A Nationwide Cohort Study.
    Chen YH; Chiang MH; Liu JS; Chang YK; Kuo KL; Hung SC; Tai HL; Hsu CC; Tarng DC
    PLoS One; 2015; 10(6):e0129922. PubMed ID: 26083376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium supplementation and long-term outcomes in chronic peritoneal dialysis patients with end-stage renal disease: a propensity score matching study.
    Zhang YF; Wang Q; Su YY; Yang S; Guo J; Luo J; Tang JM; Li HY
    Ren Fail; 2016 Nov; 38(10):1594-1600. PubMed ID: 27771983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.
    Ziyadeh N; McAfee AT; Koro C; Landon J; Arnold Chan K
    Clin Ther; 2009 Nov; 31(11):2665-77. PubMed ID: 20110009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.